Literature DB >> 3420975

Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice.

F I Farag-Mahmod1, P R Wyde, J P Rosborough, H R Six.   

Abstract

The immunogenicity and protective efficacy of formalin-inactivated whole influenza A/Bangkok/79 virus vaccine given to unprimed Swiss mice orally in capsules, in their drinking water, or by direct injection into the duodenum were studied. Virus-specific IgG and IgA antibody responses to all these methods were dose-dependent and varied according to immunization conditions. Following intranasal challenge with live A/Bangkok influenza virus, mice given greater than or equal to 66 micrograms haemagglutinin (HA) of vaccine in drinking water or capsules, and mice injected into the duodenum with greater than or equal to 0.66 microgram HA, had significantly lower virus titres in their noses and lungs than control mice comparably inoculated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420975     DOI: 10.1016/0264-410x(88)90222-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza.

Authors:  Ilona Jaspers; Katherine M Horvath; Wenli Zhang; Luisa E Brighton; Johnny L Carson; Terry L Noah
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-30       Impact factor: 6.914

3.  Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection.

Authors:  J Justin Milner; Patricia A Sheridan; Erik A Karlsson; Stacey Schultz-Cherry; Qing Shi; Melinda A Beck
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

4.  Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice.

Authors:  J M Ball; M E Hardy; R L Atmar; M E Conner; M K Estes
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  The osmotic stress response of split influenza vaccine particles in an acidic environment.

Authors:  Hyo-Jick Choi; Min-Chul Kim; Sang-Moo Kang; Carlo D Montemagno
Journal:  Arch Pharm Res       Date:  2013-10-08       Impact factor: 4.946

6.  A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

Authors:  G T Pang; R L Clancy; S E O'Reilly; A W Cripps
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells.

Authors:  Matthew J Kesic; Steven O Simmons; Rebecca Bauer; Ilona Jaspers
Journal:  Free Radic Biol Med       Date:  2011-04-19       Impact factor: 7.376

8.  Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.

Authors:  Matthew J Kesic; Megan Meyer; Rebecca Bauer; Ilona Jaspers
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Exacerbation of allergic inflammation in mice exposed to diesel exhaust particles prior to viral infection.

Authors:  Ilona Jaspers; Patricia A Sheridan; Wenli Zhang; Luisa E Brighton; Kelly D Chason; Xiaoyang Hua; Stephen L Tilley
Journal:  Part Fibre Toxicol       Date:  2009-08-14       Impact factor: 9.400

10.  A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment.

Authors:  Hyo-Jick Choi; Charles F Ebersbacher; Min-Chul Kim; Sang-Moo Kang; Carlo D Montemagno
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.